Shares of Becton Dickinson and Co (NYSE:BDX) have earned a consensus rating of “Hold” from the thirteen analysts that are covering the firm. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $184.70.
Several research firms recently weighed in on BDX. Royal Bank of Canada restated a “hold” rating and issued a $177.00 price target on shares of Becton Dickinson and in a research note on Thursday. Jefferies Group LLC restated a “buy” rating and issued a $200.00 price target on shares of Becton Dickinson and in a research note on Wednesday, March 29th. JPMorgan Chase & Co. downgraded Becton Dickinson and from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $190.00 to $175.00 in a research note on Tuesday, January 3rd. Zacks Investment Research upgraded Becton Dickinson and from a “hold” rating to a “buy” rating and set a $206.00 price target on the stock in a research note on Tuesday. Finally, Raymond James Financial, Inc. restated an “outperform” rating and issued a $180.00 price target (down previously from $200.00) on shares of Becton Dickinson and in a research note on Thursday, January 5th.
In other Becton Dickinson and news, VP Jeffrey S. Sherman sold 31,464 shares of the stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $180.02, for a total transaction of $5,664,149.28. Following the sale, the vice president now directly owns 22,094 shares in the company, valued at approximately $3,977,361.88. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.40% of the company’s stock.
A number of hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of Becton Dickinson and during the fourth quarter valued at approximately $253,005,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Becton Dickinson and during the third quarter valued at approximately $98,760,000. Generation Investment Management LLP increased its stake in shares of Becton Dickinson and by 81.8% in the third quarter. Generation Investment Management LLP now owns 1,212,740 shares of the company’s stock valued at $217,966,000 after buying an additional 545,636 shares in the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Becton Dickinson and during the fourth quarter valued at approximately $83,367,000. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Becton Dickinson and by 3.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 16,848,347 shares of the company’s stock valued at $3,028,153,000 after buying an additional 501,017 shares in the last quarter. Institutional investors and hedge funds own 82.30% of the company’s stock.
Shares of Becton Dickinson and (NYSE:BDX) traded up 0.03% during mid-day trading on Monday, hitting $183.27. The company’s stock had a trading volume of 194,845 shares. The company has a market cap of $39.00 billion, a price-to-earnings ratio of 30.50 and a beta of 1.00. The stock’s 50 day moving average price is $183.63 and its 200 day moving average price is $175.04. Becton Dickinson and has a 52-week low of $157.10 and a 52-week high of $186.11.
Becton Dickinson and (NYSE:BDX) last posted its quarterly earnings results on Thursday, February 2nd. The company reported $2.33 earnings per share for the quarter, topping the consensus estimate of $2.11 by $0.22. The company had revenue of $2.92 billion for the quarter, compared to the consensus estimate of $2.86 billion. Becton Dickinson and had a return on equity of 25.25% and a net margin of 10.54%. The firm’s quarterly revenue was down 2.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.96 EPS. Equities analysts forecast that Becton Dickinson and will post $9.44 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, March 31st. Shareholders of record on Friday, March 10th were paid a dividend of $0.73 per share. The ex-dividend date was Wednesday, March 8th. This represents a $2.92 annualized dividend and a yield of 1.59%. Becton Dickinson and’s dividend payout ratio is 48.42%.
TRADEMARK VIOLATION WARNING: This story was reported by sleekmoney and is owned by of sleekmoney. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://sleekmoney.com/analysts-set-becton-dickinson-and-co-bdx-pt-at-183-00/1739233.html.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/analysts-set-becton-dickinson-and-co-bdx-pt-at-183-00/1739233.html
Receive News & Ratings for Becton Dickinson and Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co and related companies with MarketBeat.com's FREE daily email newsletter.